FXR shaped an immunosuppressive TME in NSCLC by inducing HVEM expression through transcriptional activation, intracellular Akt, Erk1/2 and STAT3 signaling pathways, and G1/S cycle progression. Here, STAT3 is linked to non-small cell lung carcinoma.